Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry
President Trump has just signed into law HR 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. The bipartisan legislation includes almost 200 provisions intended to strengthen opioid prevention and treatment efforts and bolster law enforcement tools.
Among many other things, the new law:
…
The House of Representatives has overwhelmingly approved bipartisan legislation, HR 6, the SUPPORT for Patients and Communities Act, intended to bolster opioid prevention and treatment programs and strengthen law enforcement efforts. Among many other things, the wide-ranging legislation would:
Continue Reading House Approves Sweeping Opioid Prevention/Treatment Legislation
HHS has proposed increasing from 100 to 200 the patient limit for qualified practitioners who prescribe buprenorphine-based medication-assisted treatment under the Controlled Substances Act to expand access to treatment for opioid use disorders. Buprenorphine is an opioid medication used to treat opioid addiction that can be dispensed for take-home use, by prescription. The proposed rule…
